News by Category

Joshua Rhein (left) and Jeffrey Miller (right)

University of Minnesota expands clinical investigation of engineered iPSC-derived natural killer cells, opening U.S. clinical trial for the treatment of COVID-19

The engineered iPSC-derived natural killer (NK) cell product candidate, FT516, may help defeat the novel coronavirus.
https://twin-cities.umn.edu/news-events/university-minnesota-expands-clinical-investigation-engineered-ipsc-derived-natural
University of Minnesota, Twin Cities
08/06/2020

Pages